scholarly journals Survival Status and Predictors of Mortality Among Colorectal Cancer Patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Retrospective Follow-up Study

2020 ◽  
Vol 25 (1) ◽  
pp. 38-47
Author(s):  
Bantalem Tilaye Atinafu ◽  
Fekadu Aga Bulti ◽  
Tefera Mulugeta Demelew
2016 ◽  
Vol 150 (4) ◽  
pp. S754-S755 ◽  
Author(s):  
Kunihiko Wakamura ◽  
Shin-ei Kudo ◽  
Hideyuki Miyachi ◽  
Seiko Hayashi ◽  
Yasuharu Maeda ◽  
...  

2013 ◽  
Vol 11 (9) ◽  
pp. 1016-1021 ◽  
Author(s):  
Mario Ferri ◽  
Laura Lorenzon ◽  
Mariadele Rapazzotti Onelli ◽  
Marco La Torre ◽  
Paolo Mercantini ◽  
...  

2019 ◽  
Author(s):  
Eyob Kebede Etissa ◽  
Mathewos Assefa Assefa ◽  
Birhanu Teshome Ayele

Abstract BACKGROUND: Colorectal cancer is the third most commonly diagnosed cancer in males and the second in females worldwide. According to Addis Ababa cancer registry, it is the first in male and fourth in female in Ethiopia. However, there have not been studies on prognostic factors and survival of colorectal cancer. Hence, this study aimed to estimate survival time and identify prognostic factors. METHODS: In this institution based retrospective study, medical records review of 422 colorectal cancer patients and telephone interview was used as sources of data. Survival time was estimated using Kaplan-Meier estimator. Prognostic factors were identified using the multivariable Cox regression model. RESULTS: The median survival time was 39 months. The overall five years survival rate was 33%. Patients diagnosed with rectal cancer had 76% (HR: 1.761, 95% CI: 1.173-2.644) increased risk to die compared to colon cancer patients. Node positive patients were 3.146 (95% CI: 1.626-6.078) times likely to die compared to node negative and metastatic cancer were 4.221 (95% CI: 2.788-6.392) times likely to die compared to non-metastatic patients. Risk of death was 36.1% lesser (HR: 0.639 (95% CI: 0.418-0.977)) among those who received adjuvant therapy compared to patients who had only surgical resection. CONCLUSION: The overall survival rate is low and majority of patients were young adults at presentation. Patient’s survival is largely influenced by advanced stage at presentation and delays in administration of adjuvant therapy. Adjuvant therapy was among the good prognostic factors. Implementation of colorectal cancer screening program and early detection with timely and advanced treatment are crucial to increase patients’ survival time. KEY WORDS: Colorectal cancer, survival, prognostic factor, Cox regression, Tikur Anbessa Specialized Hospital, Addis Ababa.


2019 ◽  
Author(s):  
Eyob Kebede Etissa ◽  
Mathewos Assefa Assefa ◽  
Birhanu Teshome Ayele

Abstract BACKGROUND: Colorectal cancer is the third most commonly diagnosed cancer in males and the second in females worldwide. According to Addis Ababa cancer registry, it is the first in male and fourth in female in Ethiopia. However, there have not been studies on prognostic factors and survival of colorectal cancer. Hence, this study aimed to estimate survival time and identify prognostic factors. METHODS: In this institution based retrospective study, medical records review of 422 colorectal cancer patients and telephone interview was used as sources of data. Survival time was estimated using Kaplan-Meier estimator. Prognostic factors were identified using the multivariable Cox regression model. RESULTS: The median survival time was 39 months. The overall five years survival rate was 33%. Patients diagnosed with rectal cancer had 76% (HR: 1.761, 95% CI: 1.173-2.644) increased risk to die compared to colon cancer patients. Node positive patients were 3.146 (95% CI: 1.626-6.078) times likely to die compared to node negative and metastatic cancer were 4.221 (95% CI: 2.788-6.392) times likely to die compared to non-metastatic patients. Risk of death was 36.1% lesser (HR: 0.639 (95% CI: 0.418-0.977)) among those who received adjuvant therapy compared to patients who had only surgical resection. CONCLUSION: The overall survival rate is low and majority of patients were young adults at presentation. Patient’s survival is largely influenced by advanced stage at presentation and delays in administration of adjuvant therapy. Adjuvant therapy was among the good prognostic factors. Implementation of colorectal cancer screening program and early detection with timely and advanced treatment are crucial to increase patients’ survival time. KEY WORDS: Colorectal cancer, survival, prognostic factor, Cox regression, Tikur Anbessa Specialized Hospital, Addis Ababa.


2021 ◽  
Author(s):  
Eyerusalem Worku ◽  
Hayat Aragaw ◽  
Damitie Kebede

Abstract Background Cancer is one of the leading causes of death in the world and it is considered that every fourth person dies of it. Under-nutrition is most commonly seen in cancer patients with some types of solid tumors, various chronic diseases, as well as in older persons and young children. This can result in longer hospital stay, reduced response to therapies, increased complications to therapy and surgery proceedings, poor survival and higher care costs. This study aimed to assess the prevalence and factors associated with under-nutrition on cancer patients attending Tikur Anbessa Specialized Hospital, Ethiopia.Methods Cross-sectional study was conducted from September to October 2018 among 347 cancer patients in Tikur Anbessa Specialized hospital Addis Ababa, Ethiopia. All cancer patients 18–65 years of age who were on the 2nd cycle and above treatment phase were included. Quantitative data was collected using questionnaires and the Patient Generated-Subjective Global Assessment (PG-SGA) score. Data was entered into Epi-Info version 7 and exported and analyzed by SPSS version 20. Both bivariate and multivariate logistic regression analyses were employed to identify the associated factors. Variables with 𝑃 value of less than 0.05 were considered as significant predictors.Results The prevalence of under-nutrition according to PG-SGA score result 202 (63.1%) and 88(27.5%) of the participants were moderately and severely undernourished, respectively. BMI of the participants also showed that 206 (64.4%) and 89 (27.8%) were normal and underweight, respectively. Two hundred seventy-six (86.3%) of the patients needed critical nutrition intervention. Performance status of ≥ 2 [AOR = 7.9, 95% CI (3.05, 20.48)] and cancer stage II, III & IV [AOR = 3.47, 95% CI (1.25, 9.58)], [AOR = 3.81, 95% CI (1.17, 12.31)] and [AOR = 6.11, 95% CI (1.48, 25.14)] were significantly associated with malnutrition on cancer patients at a P-value < 0.05.Conclusion The prevalence of under-nutrition is prevalent in the study area. Performance status of ≥ 2 and cancer stages were important factors associated with malnutrition in cancer patients. Screening and evaluation of nutritional status of the patients and planning nutritional therapy such as dietary supplements or enteral nutrition to counteract malnutrition on cancer patients should be implemented.


2020 ◽  
Vol 46 (3) ◽  
pp. 429-432 ◽  
Author(s):  
S.M. Qaderi ◽  
H. Vromen ◽  
H.M. Dekker ◽  
M.W.J. Stommel ◽  
A.J.A. Bremers ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document